MAP2K6 and Alzheimer disease: Furthermore, an increase in the activation and expression levels of one of the upstream activators of p38 MAPK, MKK6, has been observed in AD brain tissue [91] and to be colocalised with activated p38 MAPK in areas containing NFTs and plaques.